Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 15
2.1 What Is This Report About? 15
3 Definitions of
Markets Covered in This Report 16
3.1 In Vitro Diagnostics 16
3.2
Clinical Chemistry Test Reagents 16
3.2.1 Laboratory Reagents 16
3.2.2
Clinical Chemistry Calibrators and Controls 16
3.2.3 Clinical Chemistry
Rapid Tests 16
3.3 Immunochemistry Test Reagents 16
3.3.1 Disease
Specific Markers 16
3.3.1.1 Tumor Markers 17
3.3.1.2 Cardiac Markers
17
3.3.2 Disease Specific Test Reagents 17
3.3.2.1 Auto-Immune Disease
17
3.3.2.2 Rheumatoid Disease 17
3.3.2.3 Anemia/ Vitamins 17
3.3.2.4 Allergy 17
3.3.3 Drug Related Testing Reagents 18
3.3.3.1
Therapeutic Drugs 18
3.3.3.2 Drug of Abuse and Toxicology 18
3.3.4
Hormone Related Testing Reagents 18
3.3.4.1 Specific Proteins 18
3.3.4.2 Fertility and Pregnancy 18
3.3.4.3 Individual/Specified hormones
18
3.3.4.4 Specific Organ Function 18
3.3.5 Immunochemistry
Calibrators and Controls 18
3.3.6 Immunochemistry Rapid Tests 18
3.4
Blood Test Reagents 19
3.4.1 Hematology Test Reagents 19
3.4.1.1
Hematology 19
3.4.1.2 Immunohaematology 19
3.4.1.3 Hematology
Calibrators and Controls 19
3.4.1.4 Immunohaematology Controls 19
3.4.2 Hemostasis Test Reagents 19
3.4.2.1 Hemostasis 19
3.4.2.2
Hemostasis Calibrators and Controls 19
3.4.2.3 Hemostasis Rapid Tests
20
3.4.3 Tissue Typing Reagents 20
3.4.4 Monoclonal Antibodies 20
3.4.5 Cytokines and Immunomodulators 20
3.4.6 Histology and Cytology
Reagents 20
3.5 Microbiology Test Reagents 20
3.5.1 Bacteriology Test
Reagents 20
3.5.1.1 Bacteriology Culture 20
3.5.1.2 Blood Culture
20
3.5.1.3 Bacteriology Identification and Susceptibility 20
3.5.2
Microbiology Calibrators and Controls 21
3.5.3 Microbiology Rapid Tests
21
3.6 Infectious Immunology Test Reagents 21
3.6.1 Bacteriology
21
3.6.2 Virology 21
3.6.2.1 Hepatitis Viruses 21
3.6.2.2
Retroviruses 21
3.6.3 Parasitology 21
3.6.4 Infectious Immunology
Calibrators and Controls 21
3.6.5 Infectious Immunology Rapid Tests 22
3.7 Genetic Test Reagents 22
3.8 Self Testing 22
3.9 Instruments
22
4 Healthcare Sector Review 23
4.1 Healthcare Sector 23
4.2
Healthcare Expenditure 23
4.3 Healthcare Infrastructure 26
4.3.1
Healthcare Personnel Data 26
4.3.2 Healthcare Facilities Data 28
4.4
Healthcare Policy 33
5 Regulation System 34
5.1 Regulation System
34
5.2 Medical Equipment Approval Process 34
5.2.1 Classification of
Medical Devices 34
5.3 Conformity Assessment Process 43
5.3.1 Class I
devices 43
5.3.2 Class IIa devices 44
5.3.3 Class IIb devices 45
5.3.4 Class III devices 46
5.4 Post Market Surveillance 47
6 Pricing
and Reimbursement 48
6.1 SHI 48
6.1.1 Private Health Insurance 48
6.1.2 Diagnosis Related Groups (DRG) 48
7 Distribution Structure 49
8
In Vitro Diagnostics In Germany 50
8.1 In Vitro Diagnostics, Germany,
Overall Revenue ($ mn), 2000-2015 50
8.2 In Vitro Diagnostics, Germany,
Company Share (2006-2007) 56
9 Blood Test Reagents In Germany 57
9.1
Blood Test Reagents Overall Revenue (2000-2015) 57
9.1.1 Haematology Test
Reagents Revenue (2000-2015) 61
9.1.2 Hemostasis Test Reagents Revenue
(2000-2015) 63
9.2 Blood Test Reagents Distribution Share (2007-2008)
65
9.3 Blood Test Reagents, Germany, Company Share (2006-2007) 66
10
Clinical Chemistry Test Reagents In Germany 67
10.1 Clinical Chemistry
Test Reagents Overall Revenue (2000-2015) 67
10.2 Clinical Chemistry Test
Reagents Distribution Share (2007-2008) 69
10.3 Clinical Chemistry Test
Reagents, Germany, Company Share (2006-2007) 70
11 Genetic Test Reagents
In Germany 71
11.1 Genetic Test Reagents Overall Revenue (2000-2015)
71
11.2 Genetic Test Reagents Distribution Share (2007-2008) 73
11.3
Genetic Test Reagents, Germany, Company Share (2006-2007) 74
12
Immunochemistry Test Reagents In Germany 75
12.1 Immunochemistry Test
Reagents Overall Revenue (2000-2015) 75
12.1.1 Disease Specific Markers
Revenue (2000-2015) 79
12.1.2 Disease Specific Test Reagents Revenue
(2000-2015) 81
12.1.3 Drug Related Testing Reagents Revenue (2000-2015)
83
12.1.4 Hormone Related Testing Reagents Revenue (2000-2015) 85
12.2
Immunochemistry Test Reagents Distribution Share (2007-2008) 87
12.3
Immunochemistry Test Reagents, Germany, Company Share (2006-2007) 88
13
Infectious Immunology Test Reagents In Germany 89
13.1 Infectious
Immunology Test Reagents Overall Revenue (2000-2015) 89
13.1.1 Virology
Revenue (2000-2015) 93
13.2 Infectious Immunology Test Reagents
Distribution Share (2007-2008) 95
13.3 Infectious Immunology Test
Reagents, Germany, Company Share (2006-2007) 96
14 Instruments In Germany
97
14.1 Instruments Overall Revenue (2000-2015) 97
14.2 Instruments
Distribution Share (2007-2008) 99
15 Microbiology Test Reagents In Germany
100
15.1 Microbiology Test Reagents Overall Revenue (2000-2015) 100
15.1.1 Bacteriology Test Reagents Revenue (2000-2015) 102
15.2
Microbiology Test Reagents Distribution Share (2007-2008) 104
15.3
Microbiology Test Reagents, Germany, Company Share (2006-2007) 105
16 Self
Testing In Germany 106
16.1 Self Testing Overall Revenue (2000-2015)
106
16.2 Self Testing Distribution Share (2007-2008) 108
16.3 Self
Testing, Germany, Company Share (2006-2007) 109
17 Overview of Key
Companies in Germany In Vitro Diagnostics Market 110
17.1 F. Hoffmann-La
Roche Ltd. Company Profile 110
17.1.1 Company Overview 110
17.1.2
Value Chain Analysis 111
17.1.2.1 Manufacturing 111
17.1.2.2 Product
Development 111
17.2 Abbott Laboratories Company Profile 113
17.2.1
Company Overview 113
17.2.2 Value Chain Analysis 114
17.2.2.1
Manufacturing 114
17.2.2.2 Product Development 114
17.2.2.3 Sales and
Marketing 116
17.3 Dade Behring Holdings, Inc. Company Profile 117
17.3.1 Company Overview 117
17.4 Beckman Coulter, Inc. Company Profile
118
17.4.1 Company Overview 118
17.4.2 Value Chain Analysis 118
17.4.2.1 Manufacturing 119
17.4.2.2 Product Development 119
17.4.2.3
Sales and Marketing 119
17.4.3 Beckman Coulter, Inc. Pipeline Products
120
17.4.3.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type
120
17.4.3.2 Beckman Coulter, Inc. Pipeline Products By Development Stage
121
17.4.3.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area
121
17.4.3.4 Beckman Coulter, Inc. Pipeline Products By News Summary
122
17.5 Ortho-Clinical Diagnostics Inc. Company Profile 123
17.5.1
Company Overview 123
17.5.2 Ortho-Clinical Diagnostics Inc. Pipeline
Products 123
17.5.2.1 Ortho-Clinical Diagnostics Inc. Pipeline Products By
Equipment Type 123
17.5.2.2 Ortho-Clinical Diagnostics Inc. Pipeline
Products By Development Stage 123
17.5.2.3 Ortho-Clinical Diagnostics Inc.
Pipeline Products By Therapy Area 124
17.5.2.4 Ortho-Clinical Diagnostics
Inc. Pipeline Products By News Summary 124
17.6 bioMerieux S.A. Company
Profile 125
17.6.1 Company Overview 125
17.6.2 Value Chain Analysis
126
17.6.2.1 Manufacturing 126
17.6.2.2 Product Development 127
17.6.2.3 Sales and Marketing 128
17.7 Siemens Healthcare Company Profile
129
17.7.1 Company Overview 129
17.7.2 Value Chain Analysis 130
17.7.2.1 Manufacturing 130
17.7.2.2 Product Development 130
17.7.2.3
Sales and Marketing 131
17.8 8sens.biognostic GmbH Company Profile 132
17.8.1 Company Overview 132
17.9 AdnaGen AG Company Profile 132
17.9.1
Company Overview 132
17.10 AESKU.DIAGNOSTICS Company Profile 132
17.10.1 Company Overview 132
17.11 B*R*A*H*M*S Aktiengesellschaft Company
Profile 133
17.11.1 Company Overview 133
17.11.2 B*R*A*H*M*S
Aktiengesellschaft Pipeline Products 133
17.11.2.1 B*R*A*H*M*S
Aktiengesellschaft Pipeline Products By Equipment Type 133
17.11.2.2
B*R*A*H*M*S Aktiengesellschaft Pipeline Products By Development Stage 134
17.11.2.3 B*R*A*H*M*S Aktiengesellschaft Pipeline Products By Therapy Area
134
17.11.2.4 B*R*A*H*M*S Aktiengesellschaft Pipeline Products By Clinical
Trials 135
17.11.2.5 B*R*A*H*M*S Aktiengesellschaft Pipeline Products By
News Summary 135
17.12 BioRepair GmbH Company Profile 136
17.12.1
Company Overview 136
17.13 Centronic GmbH Company Profile 136
17.13.1
Company Overview 136
17.14 Epigenomics AG Company Profile 137
17.14.1
Company Overview 137
17.15 Epigenomics AG Pipeline Products 137
17.15.1 Epigenomics AG Pipeline Products By Equipment Type 137
17.15.2
Epigenomics AG Pipeline Products By Development Stage 137
17.15.3
Epigenomics AG Pipeline Products By Therapy Area 138
17.15.4 Epigenomics
AG Pipeline Products By Clinical Trials 138
17.15.5 Epigenomics AG
Pipeline Products By News Summary 138
17.16 Hain Lifescience GmbH Company
Profile 139
17.16.1 Company Overview 139
17.17 Invitek Biotechnolgy &
Biodesign Ltd. Company Profile 140
17.17.1 Company Overview 140
17.17.2 Invitek Biotechnolgy & Biodesign Ltd. Pipeline Products 140
17.17.2.1 Invitek Biotechnolgy & Biodesign Ltd. Pipeline Products By Equipment
Type 140
17.17.2.2 Invitek Biotechnolgy & Biodesign Ltd. Pipeline Products
By Development Stage 140
17.17.2.3 Invitek Biotechnolgy & Biodesign Ltd.
Pipeline Products By Therapy Area 140
17.18 Serion Immundiagnostica GmbH
Company Profile 141
17.18.1 Company Overview 141
17.19 Viramed Biotech
AG Company Profile 141
17.19.1 Company Overview 141
18 Financial Deals
Landscape 142
18.1 Partnerships 142
18.1.1 Epigenomics Enters Into an
Agreement with Quest Diagnostics 142
18.1.2 Kreatech Enters Into An
Agreement With BioMicro Systems 143
18.1.3 Medizinische Hochschule
Hannover Signs An Agreement With Roche Diagnostics 144
18.1.4 Exiqon Signs
An Agreement With Roche Diagnostics 145
19 Recent Developments 146
19.1 Strategy and Business Planning 146
19.1.1 Oct 09, 2008: Abbott Opens
New Research Facility and Pilot Plant in Ludwigshafen 146
19.1.2 Oct 01,
2008: Roche Invests CHF215 Million In Diagnostics Facility At Penzberg, Munich
146
19.2 Legal and Regulatory 147
19.2.1 Jan 22, 2009: QIAGEN and
Applied Biosystems Settle All Disputes Over Real-Time PCR Thermal Cycler
Patents 147
19.3 Product News 148
19.3.1 Feb 25, 2009: B*R*A*H*M*S
Submits MR-proANP Kryptor For FDA Approval 148
19.3.2 Oct 16, 2008: Primo
Star iLED-Faster Detection Of Tuberculosis Using A New Microscope From Carl
Zeiss 148
19.3.3 Oct 16, 2008: SIRS-Lab Receives ISO Certification For
VYOO, Molecular In-Vitro Sepsis Diagnostics 149
20 Appendix 150
20.1
Global Markets Direct Research Methodology 150
20.2 Coverage 151
20.3
Secondary Research 151
20.4 Primary Research 152
20.5 Models 152
20.6 Forecasts 153
20.7 Expert Panel Validation 153
20.8 Currency
Conversion 154
20.9 Contact Us 155
20.10 Disclaimer 155
1.1
List of Tables
Table 1: Healthcare Expenditure in Germany, (€m), 2000 -
2006 23
Table 2: Healthcare Personnel by Region in Germany, 2007 26
Table 3: Doctors by Specialty in Germany, 2000-2004 27
Table 4: Hospitals
by Region in Germany, 2004 28
Table 5: Hospitals and Beds by Region in
Germany, 2007 29
Table 6: Rehabilitation Centers by Region in Germany,
2004 30
Table 7: Rehabilitation Center Beds by Region in Germany, 2004
31
Table 8: Discharges by Diagnosis in Germany, 2004 32
Table 9:
In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015 50
Table
10: In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-2015 51
Table 11: In Vitro Diagnostics, Germany, Overall Revenue ($ mn),
Historic, 2000-2008 53
Table 12: In Vitro Diagnostics, Germany,
Overall Revenue ($ mn), Forecast, 2008-2015 55
Table 13: In Vitro
Diagnostics, Germany, Company Share by Revenue ($ mn), 2006-2007 56
Table
14: Blood Test Reagents, Germany, Revenue ($ mn) by Segment, Historic,
2000-2008 58
Table 15: Blood Test Reagents, Germany, Revenue ($ mn)
by Segment, Forecast, 2008-2015 60
Table 16: Haematology Test
Reagents, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 61
Table 17: Haematology Test Reagents, Germany, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 62
Table 18: Hemostasis Test
Reagents, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 63
Table 19: Hemostasis Test Reagents, Germany, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 64
Table 20: Blood Test Reagents,
Germany, Distribution Share by Revenue ($mn), 2007-2008 65
Table 21:
Blood Test Reagents, Germany, Company Share by Revenue ($ mn), 2006-2007
66
Table 22: Clinical Chemistry Test Reagents, Germany, Revenue ($
mn) by Segment, Historic, 2000-2008 67
Table 23: Clinical Chemistry
Test Reagents, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 68
Table 24: Clinical Chemistry Test Reagents, Germany, Distribution Share
by Revenue ($mn), 2007-2008 69
Table 25: Clinical Chemistry Test
Reagents, Germany, Company Share by Revenue ($ mn), 2006-2007 70
Table 26:
Genetic Test Reagents, Germany, Revenue ($ mn), Historic, 2000-2008
71
Table 27: Genetic Test Reagents, Germany, Revenue ($ mn),
Forecast, 2008-2015 72
Table 28: Genetic Test Reagents, Germany,
Distribution Share by Revenue ($mn), 2007-2008 73
Table 29: Genetic
Test Reagents, Germany, Company Share by Revenue ($ mn), 2006-2007 74
Table 30: Immunochemistry Test Reagents, Germany, Revenue ($ mn) by
Segment, Historic, 2000-2008 76
Table 31: Immunochemistry Test
Reagents, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 78
Table
32: Disease Specific Markers, Germany, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 79
Table 33: Disease Specific Markers, Germany,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 80
Table 34:
Disease Specific Test Reagents, Germany, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 81
Table 35: Disease Specific Test Reagents,
Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 82
Table 36:
Drug Related Testing Reagents, Germany, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 83
Table 37: Drug Related Testing Reagents,
Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 84
Table 38:
Hormone Related Testing Reagents, Germany, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 85
Table 39: Hormone Related Testing Reagents,
Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 86
Table 40:
Immunochemistry Test Reagents, Germany, Distribution Share by Revenue
($mn), 2007-2008 87
Table 41: Immunochemistry Test Reagents, Germany,
Company Share by Revenue ($ mn), 2006-2007 88
Table 42: Infectious
Immunology Test Reagents, Germany, Revenue ($ mn) by Segment, Historic,
2000-2008 90
Table 43: Infectious Immunology Test Reagents, Germany,
Revenue ($ mn) by Segment, Forecast, 2008-2015 92
Table 44: Virology,
Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 93
Table 45:
Virology, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
94
Table 46: Infectious Immunology Test Reagents, Germany,
Distribution Share by Revenue ($mn), 2007-2008 95
Table 47:
Infectious Immunology Test Reagents, Germany, Company Share by Revenue ($ mn),
2006-2007 96
Table 48: Instruments, Germany, Revenue ($ mn),
Historic, 2000-2008 97
Table 49: Instruments, Germany, Revenue ($
mn), Forecast, 2008-2015 98
Table 50: Instruments, Germany,
Distribution Share by Revenue ($mn), 2007-2008 99
Table 51:
Microbiology Test Reagents, Germany, Revenue ($ mn) by Segment, Historic,
2000-2008 100
Table 52: Microbiology Test Reagents, Germany, Revenue
($ mn) by Segment, Forecast, 2008-2015 101
Table 53: Bacteriology
Test Reagents, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
102
Table 54: Bacteriology Test Reagents, Germany, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 103
Table 55: Microbiology Test
Reagents, Germany, Distribution Share by Revenue ($mn), 2007-2008 104
Table 56: Microbiology Test Reagents, Germany, Company Share by Revenue
($ mn), 2006-2007 105
Table 57: Self Testing, Germany, Revenue ($
mn), Historic, 2000-2008 106
Table 58: Self Testing, Germany, Revenue
($ mn), Forecast, 2008-2015 107
Table 59: Self Testing, Germany,
Distribution Share by Revenue ($mn), 2007-2008 108
Table 60: Self
Testing, Germany, Company Share by Revenue ($ mn), 2006-2007 109
Table 61:
Beckman Coulter, Inc. Pipeline Products by Equipment Type 120
Table
62: Beckman Coulter, Inc. Pipeline Products By Development Stage 121
Table 63: Beckman Coulter, Inc. Pipeline Products By Therapy Area 121
Table 64: Beckman Coulter, Inc. Pipeline Products By News Summary 122
Table 65: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment
Type 123
Table 66: Ortho-Clinical Diagnostics Inc. Pipeline Products
By Development Stage 123
Table 67: Ortho-Clinical Diagnostics Inc.
Pipeline Products By Therapy Area 124
Table 68: Ortho-Clinical
Diagnostics Inc. Pipeline Products By News Summary 124
Table 69:
B*R*A*H*M*S Aktiengesellschaft Pipeline Products by Equipment Type 133
Table 70: B*R*A*H*M*S Aktiengesellschaft Pipeline Products By Development
Stage 134
Table 71: B*R*A*H*M*S Aktiengesellschaft Pipeline Products
By Therapy Area 134
Table 72: B*R*A*H*M*S Aktiengesellschaft Pipeline
Products By Clinical Trials 135
Table 73: B*R*A*H*M*S
Aktiengesellschaft Pipeline Products By News Summary 135
Table 74:
Epigenomics AG Pipeline Products by Equipment Type 137
Table 75:
Epigenomics AG Pipeline Products By Development Stage 137
Table 76:
Epigenomics AG Pipeline Products By Therapy Area 138
Table 77:
Epigenomics AG Pipeline Products By Clinical Trials 138
Table 78:
Epigenomics AG Pipeline Products By News Summary 138
Table 79:
Invitek Biotechnolgy & Biodesign Ltd. Pipeline Products by Equipment Type
140
Table 80: Invitek Biotechnolgy & Biodesign Ltd. Pipeline Products
By Development Stage 140
Table 81: Invitek Biotechnolgy & Biodesign
Ltd. Pipeline Products By Therapy Area 140
Table 82: Epigenomics
Enters Into An Agreement With Quest Diagnostics 142
Table 83:
Kreatech Enters Into An Agreement With BioMicro Systems 143
Table 84:
Medizinische Hochschule Hannover Signs An Agreement With Roche Diagnostics
144
Table 85: Exiqon Signs An Agreement With Roche Diagnostics
145
Table 86: USD to Local Currency, Average Exchange Rate 2008 154
1.2 List of Figures
Figure 1: Healthcare Expenditure Sources in
Germany, 2006 24
Figure 2: Healthcare Financing Framework in Germany, 2007
25
Figure 3: Flowchart for Classification of Non-invasive Devices in
Germany, 2007 35
Figure 4: Flowchart for Classification of Invasive
Devices in Germany, 2007 36
Figure 5: Flowchart for Classification of
Invasive Devices in Germany, 2007 37
Figure 6: Classification of Invasive
Devices in Germany, 2007 38
Figure 7: Classification of Invasive Devices
in Germany, 2007 39
Figure 8: Flowchart for Classification of Active
Devices in Germany, 2007 40
Figure 9: Flowchart for Classification of
Active Devices in Germany, 2007 41
Figure 10: Flowchart for Classification
of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007
42
Figure 11: Conformity Assessment of Class-I Medical Devices in Germany,
2007 43
Figure 12: Conformity Assessment of Class-IIa Medical Devices in
Germany, 2007 44
Figure 13: Conformity Assessment of Class-IIb Medical
Devices in Germany, 2007 45
Figure 14: Conformity Assessment of Class-III
Medical Devices in Germany, 2007 46
Figure 15: In Vitro Diagnostics,
Germany, Overall Revenue ($ mn), 2000-2015 50
Figure 16: In Vitro
Diagnostics, Germany, Cross-Category Analysis, 2000-2015 51
Figure 17:
In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Historic, 2000-2008
52
Figure 18: In Vitro Diagnostics, Germany, Overall Revenue ($ mn),
Forecast, 2008-2015 54
Figure 19: In Vitro Diagnostics, Germany,
Company Share (%), 2007 56
Figure 20: Blood Test Reagents, Germany,
Revenue ($ mn) by Segment, Historic, 2000-2008 57
Figure 21: Blood
Test Reagents, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 59
Figure 22: Haematology Test Reagents, Germany, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 61
Figure 23: Haematology Test
Reagents, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 62
Figure 24: Hemostasis Test Reagents, Germany, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 63
Figure 25: Hemostasis Test
Reagents, Germany, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 64
Figure 26: Blood Test Reagents, Germany, Company Share (%), 2007 66
Figure 27: Clinical Chemistry Test Reagents, Germany, Revenue ($ mn) by
Segment, Historic, 2000-2008 67
Figure 28: Clinical Chemistry Test
Reagents, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 68
Figure 29: Clinical Chemistry Test Reagents, Germany, Company Share (%),
2007 70
Figure 30: Genetic Test Reagents, Germany, Revenue ($ mn),
Historic, 2000-2008 71
Figure 31: Genetic Test Reagents, Germany,
Revenue ($ mn), Forecast, 2008-2015 72
Figure 32: Genetic Test
Reagents, Germany, Company Share (%), 2007 74
Figure 33:
Immunochemistry Test Reagents, Germany, Revenue ($ mn) by Segment, Historic,
2000-2008 75
Figure 34: Immunochemistry Test Reagents, Germany,
Revenue ($ mn) by Segment, Forecast, 2008-2015 77
Figure 35: Disease
Specific Markers, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
79
Figure 36: Disease Specific Markers, Germany, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 80
Figure 37: Disease Specific Test
Reagents, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 81
Figure 38: Disease Specific Test Reagents, Germany, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 82
Figure 39: Drug Related Testing
Reagents, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 83
Figure 40: Drug Related Testing Reagents, Germany, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 84
Figure 41: Hormone Related
Testing Reagents, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
85
Figure 42: Hormone Related Testing Reagents, Germany, Revenue ($
mn) by Sub-Segment, Forecast, 2008-2015 86
Figure 43: Immunochemistry
Test Reagents, Germany, Company Share (%), 2007 88
Figure 44:
Infectious Immunology Test Reagents, Germany, Revenue ($ mn) by Segment,
Historic, 2000-2008 89
Figure 45: Infectious Immunology Test
Reagents, Germany, Revenue ($ mn) by Segment, Forecast, 2008-2015 91
Figure 46: Virology, Germany, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 93
Figure 47: Virology, Germany, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 94
Figure 48: Infectious Immunology
Test Reagents, Germany, Company Share (%), 2007 96
Figure 49:
Instruments, Germany, Revenue ($ mn), Historic, 2000-2008 97
Figure 50:
Instruments, Germany, Revenue ($ mn), Forecast, 2008-2015 98
Figure 51:
Microbiology Test Reagents, Germany, Revenue ($ mn) by Segment, Historic,
2000-2008 100
Figure 52: Microbiology Test Reagents, Germany, Revenue
($ mn) by Segment, Forecast, 2008-2015 101
Figure 53: Bacteriology
Test Reagents, Germany, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
102
Figure 54: Bacteriology Test Reagents, Germany, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 103
Figure 55: Microbiology Test
Reagents, Germany, Company Share (%), 2007 105
Figure 56: Self
Testing, Germany, Revenue ($ mn), Historic, 2000-2008 106
Figure 57:
Self Testing, Germany, Revenue ($ mn), Forecast, 2008-2015 107
Figure 58:
Self Testing, Germany, Company Share (%), 2007 109
Figure 59: F.
Hoffmann-La Roche Ltd Value Chain Analysis 111
Figure 60: Abbott
Laboratories Value Chain Analysis 114
Figure 61: Beckman Coulter,
Inc. Value Chain Analysis 118
Figure 62: Biomerieux Sa Value Chain
Analysis 126
Figure 63: Siemens Medical Solutions Value Chain
Analysis 130
Figure 64: Global Markets Direct Methodology 150
|
Related Report
|
View Cart
